Table 2.
Univariate analysis of the clinicoradiological features in the training set
| csPCa (n = 101) | non-csPCa (n = 90) | p | |
|---|---|---|---|
| Age (year) | 73.0 (68.0–78.0) | 69.5 (65.8–76.3) | 0.032* |
| PSA (ng/ml) | 36.2 (18.7–49.0) | 15.9 (9.7–21.1) | <0.001* |
| PSAD (ng/ml2) | 0.64 (0.30–1.10) | 0.27 (0.15–0.45) | <0.001* |
| Volume (mm3) | 53.2 (33.7–74.9) | 61.2 (42.7–83.4) | 0.073 |
| DRE (+) | 37 (36.6%) | 46 (32.5%) | 0.537 |
| Hypertension (+) | 46 (45.5%) | 50 (55.6%) | 0.167 |
| Smoke (+) | 32 (31.7%) | 48 (53.3%) | 0.002* |
| Alcohol (+) | 16 (15.8%) | 13 (14.4%) | 0.788 |
| Cr | 0.70 (0.34–1.18) | 1.06 (0.40–1.70) | 0.018* |
| Cho | 3.02 (1.94–4.20) | 2.07 (1.59–2.90) | <0.001* |
| Cit | 2.01 (1.09–3.12) | 4.49 (2.40–6.83) | <0.001* |
| (Cho + Cr)/Cit | 2.03 (1.34–3.14) | 0.68 (0.47–1.20) | <0.001* |
| Location | <0.001* | ||
| PZ | 83(82.2%) | 45 (50.0%) | |
| TZ | 18 (17.8%) | 45 (50.0%) | |
| PIRADS score | <0.001* | ||
| 3 | 17 (16.8%) | 51 (56.7%) | |
| 4 | 26 (25.7%) | 25 (27.8%) | |
| 5 | 58 (57.4%) | 14 (15.6%) |
Data are presented as medians ± interquartile ranges (IQR) or numbers of patients with percentages in parentheses
P value was calculated by using the Mann–Whitney U test for continuous variables and Pearson’s χ2 test for categoric variables
*, p<0.05